Log in to save to my catalogue

Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine durin...

Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine durin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_osti_scitechconnect_1909325

Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine during co-administration

About this item

Full title

Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine during co-administration

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2023-01, Vol.41 (4), p.955-964

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

AbstractIntroductionA hepatitis B vaccination (HepB) series with an initial dose of hepatitis B immune globulin (HBIG) is the recommended prophylaxis for infants born to mothers with chronic hepatitis B virus (HBV) infection and for HBV-exposed persons without known protection. The HepB and HBIG are administered at different sites (limbs). Instance...

Alternative Titles

Full title

Assessing the impact of hepatitis B immune globulin (HBIG) on responses to hepatitis B vaccine during co-administration

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_osti_scitechconnect_1909325

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_osti_scitechconnect_1909325

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2022.12.055

How to access this item